Home>
US Stocks>
Briacell Therapeutics

Briacell Therapeutics share price today

(BCTX)

Briacell Therapeutics share price is $0.54 & ₹46.01 as on 25 Dec 2024, 2.30 'hrs' IST

$0.54

▲

0.01

(1.49%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Briacell Therapeutics share price in Dollar and Rupees. Guide to invest in Briacell Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Briacell Therapeutics. Get details on the Indian mutual funds that are investing in Briacell Therapeutics. Get Analyst recommendations and forecasts along with all the Briacell Therapeutics's financials.

Briacell Therapeutics share price movements

Today's Low: $0.51
Today's High: $0.57
$0.54
5.56%
Downside
Day's Volatility :10.35%
Upside
5.08%
52 Weeks Low: $0.46
52 Weeks High: $5.97
$0.54
14.06%
Downside
52 Weeks Volatility :92.23%
Upside
90.95%

Briacell Therapeutics Returns

Period	Briacell Therapeutics Corp	Index (Russel 2000)
3 Months	-24.9%	0.0%
6 Months	-48.37%	0.0%
1 Year	-89.77%	0.0%
3 Years	-93.92%	-21.1%

Briacell Therapeutics Key Statistics

in dollars & INR

Previous Close	$0.529
Open	$0.54
Today's High	$0.5689
Today's Low	$0.51
Market Capitalization	$23.7M
Today's Volume	$546.3K
52 Week High	$5.97
52 Week Low	$0.4641
Revenue TTM	$0.0
EBITDA	$-33.2M
Earnings Per Share (EPS)	$-0.89
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-206.01%

How to invest in Briacell Therapeutics from India?

It is very easy for Indian residents to invest directly in Briacell Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Briacell Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Briacell Therapeutics or BCTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Briacell Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Briacell Therapeutics shares which would translate to 1.578 fractional shares of Briacell Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Briacell Therapeutics, in just a few clicks!

Returns in Briacell Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Briacell Therapeutics investment value today

Current value as on today

₹12,524

Returns

₹87,476

(-87.48%)

Returns from Briacell Therapeutics Stock

₹89,714 (-89.71%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Briacell Therapeutics

895%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Briacell Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 895% more investors are searching Briacell Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Briacell Therapeutics

Vontobel Holding Ltd.
0.22%
HRT FINANCIAL LLC
0.21%
Onyx Bridge Wealth Group LLC
0.14%
Group One Trading, LP
0.10%
BMO Capital Markets Corp.
0.10%
Bank of Montreal
0.10%

Analyst Recommendation on Briacell Therapeutics

Buy

80%Buy

20%Hold

0%Sell

Based on 5 Wall street analysts offering stock ratings for Briacell Therapeutics(by analysts ranked 0 to 5 stars)

Based on 5 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Briacell Therapeutics

What analysts predicted

Upside of 2677.78%

Current:

$0.54

Target:

$15.00

Insights on Briacell Therapeutics

Price Movement
In the last 7 days, BCTX stock has moved down by -8.2%
BCTX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 116.9%
BCTX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 119.4%

Briacell Therapeutics Technicals Summary

Sell

Neutral

Buy

Briacell Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Briacell Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Briacell Therapeutics Corp	-28.14%	-48.37%	-89.77%	-93.92%	-86.23%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Briacell Therapeutics Corp	NA	NA	NA	-1.14	-2.06	-1.26	NA	-0.13
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Briacell Therapeutics Corp	Buy	$23.7M	-86.23%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Briacell Therapeutics

briacell therapeutics corp immunotherapy approaches to cancer management briacell is a los angeles headquartered biotechnology company focused on immunotherapy treatments for cancer management. to date, the company has been successful in developing its patented "briavax" vaccine and implementing two compelling fda phase-i studies with late-stage breast cancer patients, demonstrating unique and unprecedented results. briacell is focused on aggressively moving towards launching its next clinical trial, a phase-i/ii study, in order to apply its vaccine to a larger number of breast cancer patients and effectively progress its technology along the value chain. while the current corporate focus is breast cancer, the company has an eye towards potentially applying its vaccine technology to certain other cancer types as well.

Organization	Briacell Therapeutics
Employees	0
CEO	Dr. William V. Williams M.D.
Industry	Miscellaneous

Management People of Briacell Therapeutics

Name	Title
Dr. William V. Williams M.D.	CEO, President & Director
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.	CFO & Corporate Secretary
Dr. Miguel A. Lopez-Lago Ph.D.	Chief Scientific Officer
Dr. Giuseppe Del Priore M.D., M.P.H., MPH	Chief Medical Officer
Dr. Charles Louis Wiseman FACP, M.D.	Founder, Principal Research Advisor & Member of Scientific Advisory Board

Important FAQs about investing in Briacell Therapeutics from India :

What is Briacell Therapeutics share price today?

Briacell Therapeutics share price today stands at $0.54, Open: $0.54 ; Previous Close: $0.53 ; High: $0.57 ; Low: $0.51 ; 52 Week High: $5.97 ; 52 Week Low: $0.46. The stock opens at $0.54, after a previous close of $0.53. The stock reached a daily high of $0.57 and a low of $0.51, with a 52-week high of $5.97 and a 52-week low of $0.46.

Can Indians buy Briacell Therapeutics shares?

Yes, Indians can invest in the Briacell Therapeutics (BCTX) from India.

With INDmoney, you can buy Briacell Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Briacell Therapeutics at zero transaction cost.

How can I buy Briacell Therapeutics shares from India?

It is very easy to buy Briacell Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Briacell Therapeutics be purchased?

Yes, you can buy fractional shares of Briacell Therapeutics with INDmoney app.

What are the documents required to start investing in Briacell Therapeutics stocks?

To start investing in Briacell Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.